MedTrace Logo

Motivation and Barriers for Exercise in Patients With Anxiety or Posttraumatic Stress Disorder

NCT03818425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 460

Last updated 2020-03-27

No results posted yet for this study

Summary

Relevance and Aim: There has been increasing research interest in sport preferences and motivational factors as well as barriers that restrain from engaging in sport activities in people suffering from mental illnesses. Anxiety disorders are one of the leading mental disorders worldwide. Exercise has previously shown anxiolytic effects and is discussed as an adjunctive treatment option in clinical practice. This study aims to depict motivation and barriers in patients with anxiety or posttraumatic stress disorders.

Design and Participants: Observational study of patients diagnosed with anxiety disorder or posttraumatic stress disorder (ICD-10)

Measurements: Structured questionnaire compounded of validated scales for current physical activity, sport motivation, exercise preferences, perceived barriers , self-efficacy, social support for physical activity, motivation,enjoyment, quality of life as well as sociodemographic data.

Duration: The questionnaire will require approximately 20 minutes, the overall duration is 3 months. Personal assistance for completing the questionnaire will be provided if necessary.

Conditions

  • Exercise
  • Motivation

Sponsors & Collaborators

  • Medical University Innsbruck

    collaborator OTHER

  • Universitaet Innsbruck

    lead OTHER

Principal Investigators

  • Martin Kopp, PhD, Prof. · Department of Sport Science, University of Innsbruck

  • Barbara Sperner-Unterweger, MD, Prof. · Department of Psychosomatics, Medical University of Innsbruck

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-07
Primary Completion
2019-10-01
Completion
2019-12-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03818425 on ClinicalTrials.gov